BlinkLab Presents at TechKnow Invest Roadshow 2026

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”) is pleased to advise shareholdersand investors that the Company will be presenting at the TechKnow Invest Roadshow 2026 as part of both the Melbourne and Sydney events.

Chairman, Mr Brian Leedman, and Managing Director/CEO, Dr. Henk-Jan Boele, will be presenting on behalf of the Company as part of the day’s proceedings, providing investors with an update on BlinkLab’s latest progress, including its U.S. FDA 510(k) registrational trial for autism, expanding portfolio of clinical and research collaborations, and the growing pipeline of applications for its neurometric assessment technology.

TechKnow Invest Roadshow – Melbourne

Sofitel Melbourne on Collins, Victoria
Monday, 27 July 2026 at 12:45pm AEST

TechKnow Invest Roadshow – Melbourne

Swissôtel Sydney, New South Wales
Wednesday, 29 July 2026 at 11:45am AEST

Registration to Attend:

https://www.techknowinvestroadshow.com.au/registration

The TechKnow Invest Roadshow is an annual event series that brings together ASX-listed companies across Technology, Biotech, Medtech, and Resources Technology. It gives investors and stockbrokers the opportunity to connect with leaders and subject matter experts from acrossAustralia’s technology scene.

This announcement has been authorised for release by the Board of BlinkLab Limited.